Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints Pfizer's Rita Balice-Gordon to lead neurobiology research

She will be based at the firm's Framingham, Massachusetts R&D site

Sanofi Rita Balice-GordonSanofi has appointed Rita Balice-Gordon as head of its neurobiology research therapeutic area.

She joins the French pharma firm from Pfizer, where she served as head of circuits, neurotransmitters and signaling in the its neuroscience and pain research unit.

During her time there she led a global team and was responsible for the company's worldwide research and development postdoctoral programme.

Prior to her time at Pfizer Balice-Gordon was professor of neuroscience and chair of the neuroscience graduate group in the Perelman School of Medicine at the University of Pennsylvania, where she currently holds an adjunct appointment.

In her new role at Sanofi Balice-Gordon will based at the firm's Framingham, Massachusetts R&D site and lead research efforts associated with Sanofi's early portfolio in neurobiology, including neurodegeneration, neuroinflammation and central nervous system inherited diseases.

18th May 2016

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...